financetom
Business
financetom
/
Business
/
Pfizer Names Andrew Baum as Chief Strategy, Innovation Officer
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pfizer Names Andrew Baum as Chief Strategy, Innovation Officer
May 6, 2024 4:54 AM

07:42 AM EDT, 05/06/2024 (MT Newswires) -- Pfizer ( PFE ) said Monday it appointed Andrew Baum as chief strategy and innovation officer, effective June 3.

The company said Baum joins the company from Citi where he was head of global healthcare and managing director of equity research.

Baum succeeds Aamir Malik, who recently became Pfizer's ( PFE ) chief US commercial officer.

Price: 27.94, Change: +0.13, Percent Change: +0.47

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Broadcom Insider Sold Shares Worth $49,879,007, According to a Recent SEC Filing
Broadcom Insider Sold Shares Worth $49,879,007, According to a Recent SEC Filing
Sep 12, 2025
05:12 PM EDT, 09/12/2025 (MT Newswires) -- Hock E Tan, Director, President and CEO, on September 10, 2025, sold 148,154 shares in Broadcom ( AVGO ) for $49,879,007. Following the Form 4 filing with the SEC, Tan has control over a total of 1,308,834 common shares of the company, with 482,836 shares held directly and 825,998 controlled indirectly. SEC Filing:...
Planet Labs Closes Upsized Offering of Senior Notes due 2030
Planet Labs Closes Upsized Offering of Senior Notes due 2030
Sep 12, 2025
04:45 PM EDT, 09/12/2025 (MT Newswires) -- Planet Labs PBC ( PL ) said late Friday it has closed an upsized $460 million offering of 0.50% convertible senior notes due 2030. The offering includes the full exercise of an overallotment option, it said. ...
Tg Therapeutics Insider Sold Shares Worth $672,268, According to a Recent SEC Filing
Tg Therapeutics Insider Sold Shares Worth $672,268, According to a Recent SEC Filing
Sep 12, 2025
04:47 PM EDT, 09/12/2025 (MT Newswires) -- Sagar Lonial, Director, on September 11, 2025, sold 20,852 shares in Tg Therapeutics ( TGTX ) for $672,268. Following the Form 4 filing with the SEC, Lonial has control over a total of 94,061 common shares of the company, with 94,061 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1001316/000143774925028952/xslF345X05/rdgdoc.xml ...
Marlton Partners Comments on 180 Degree Capital Corp. and Mount Logan Capital Inc. Business Combination
Marlton Partners Comments on 180 Degree Capital Corp. and Mount Logan Capital Inc. Business Combination
Sep 12, 2025
Revised Terms Delivering 110% of NAV Validates TURN Shareholder Value CHICAGO, Sept. 12, 2025 /PRNewswire/ -- Marlton Partners L.P. (together with its affiliates and group members, Marlton or we), beneficial owners of approximately 5.8% of the outstanding stock of 180 Degree Capital Corp. ( TURN ) , today issued the following statement in response to the business combination of the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved